Developing a multidisciplinary medication safety program in a hospital;Programa multidisciplinario de prevención de errores de medicación en un hospital

Revista de Calidad Asistencial

Volumn 20, Issue 2, 2005, Pages 79-89

  Otero, María José ^a   Codina, Carlos ^b   Robles, Dolores ^b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Adverse effects; Hospitals; Medication errors; Medication Systems; Safety management

Indexed keywords

AUTOMATION; CONTINUING EDUCATION; CULTURAL ANTHROPOLOGY; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH SERVICE; HOSPITAL; HOSPITAL MANAGEMENT; HOSPITALIZATION; MEDICATION ERROR; NURSE; PHARMACIST; PHYSICIAN; PRACTICE GUIDELINE; PROPHYLAXIS; REVIEW; SAFETY;

EID: 17844371034     PISSN: 1134282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1134-282x(08)74727-4     Document Type: Review

References (57)

1. Aranaz JM, Aibar C, Gea MT, León MT. Efectos adversos en la asistencia hospitalaria. Med Clin (Barc). 2004;123:21-5.
2. Leape LL, Brennan TA, Laird NL, Lawthers AG, Localio R, Barnes BA, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med. 1991;324:377-84.
3. Neale G, Woloshynowych M, Vincent C. Exploring the causes of adverse events in NHS hospital practice. J R Soc Med. 2001;94:322-30.
4. Baker GR, Norton PG, Flintoft V, Biais R, Brown A, Cox J, et al. The Canadian Adverse Events study: the incidence of adverse events among hospital patients in Canada. CMAJ. 2004;170:1678-86.
5. Alonso Hernández P, Otero López MJ, Maderuelo Fernández JA. Ingresos hospitalarios causados por medicamentos: incidencia, características y coste. Farmacia Hosp (Madrid). 2002;26:77-89.
6. Rodríguez-Monguió R, Otero MJ, Rovira J. Assessing the economic impact of adverse drug effects. Pharmacoeconomics. 2003;21:623-50.
7. Kanjanarat P, Winterstein AG, Johns TE, Hatton RC, González-Rothi R, Segal R. Nature of preventable adverse drug events in hospitals: a literature review. Am J Health-Syst Pharm. 2003;60:1750-9.
8. Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289:1107-16.
9. Bates DW, Cullen DJ, Laird N, Petersen L, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. JAMA. 1995;274:29-34.
10. Otero López MJ. Errores de medicación y gestión de riesgos. Rev Esp Salud Pública. 2003;77:527-40.
11. Kohn LT, Corrigan JM, Donaldson MS, editors. To err is human: building a safer health system. Committee on Health Care in America. Institute of Medicine. Washington (DC): National Academy Press; 1999.
12. Expert Group on Learning from Adverse Events in the NHS. An organisation with a memory. London: Stationery Office, 2000. Disponible en: www.doh.gov.uk/orgmemreport/index.htm
13. Australian Council for Safety and Quality in Health Care. Second national report on patient safety improving medication safety. Safety + Quality Council. July 2002.
14. National Steering Committee on Patient Safety. Building a Safer System: a national integrated strategy for improving patient safety in Canadian Health care. September 2002.
15. World Health Organization. Quality of care: patient safety. WHA55.18. Fifty-fifth World Health Assembly. Geneva, 18 May 2002. Disponible en: www.who.int/multimedia
16. Council of Europe and WHO Regional Office for Europe. Consensus document. Expert Meeting on Medication Safety. The Hague, 22 November 2002. disponible en: www.coe.int/T/E/Social_Cohesion/soc-sp/Public_Health/Pharma_and_Medicine
17. Reason J. Human error: models and management. BMJ. 2000;320:768-70.
18. First Do No Harm: a Practical Guide to Medication Safety and JCAHO compliance. Marblehead, MA: Opus Communications; 1999.
19. Otero MJ. El papel del farmacéutico en la prevención de los errores de medicación. En: Formación Continuada para Farmacéuticos de Hospital II. Módulo 3. Barcelona: Fundación Promedic; 2004. p. 5-44.
20. ECRI. Healthcare risk managers prepare for new JCAHO patient safety requirements. The Risk Management Reporter. 2001:20(4):1-9.
21. Leape LL, Kabcenell A, Berwick DM, Roessner J. Breakthrough Series Guide: reducing adverse drug events. Boston (MA): Institute for Healthcare Improvement; 1998.
22. Cohen MR, Smetzer JL. Risk analysis and treatment. En: Cohen MR, editor. Medication Errors. Washington (DC): American Pharmaceutical Association; 1999. p. 20.1-20.34.
23. Institute for Safe Medication Practices. Recommended practices for patient safety teams. Huntingdon Valley (PA): ISMP; 2001.
24. a ed. Madrid: SCM, SL (Doyma); 2002. p. 713-47.
25. Barker KN, Flynn EA, Pepper GA. Observation method of detecting medication errors. Am J Health-Syst Pharm. 2002;59:2314-6.
26. Bates DW. Using information technology to screen for adverse drug events. Am J Health-Syst Pharm. 2002;59:2317-9.
27. Lesar TS. Practitioner intervention-reporting systems for measuring the quality of drug use. Am J Health-Syst Pharm. 2002;59:2320-2.
28. Kaushal R. Using chart review to screen for medication errors and adverse drug events. Am J Health-Syst Pharm. 2002;59:2323-5.
29. Shaw Phillips MA. Voluntary reporting of medication errors. Am J Health-Syst Pharm. 2002;59:2326-8.
30. Schneider PJ. Using technology to enhance measurement of drug-use safety. Am J Health-Syst Pharm. 2002;59:2330-2.
31. Schneider PJ. Measuring medication safety in hospitals. Workshop summaries. Am J Health-Syst Pharm. 2002;59:2333-6.
32. Otero López MJ, Tuset Creus M, Tamés Alonso MJ, Pérez Encinas M, en representación del grupo de trabajo Ruiz-Jarabo 2000. Programa estandarizado para el análisis y registro de los errores de medicación en los hospitales. XIX Congreso de la Sociedad Española de Calidad Asistencial, Octubre 2001, Murcia.
33. Robles MD, Castelló M, Codina C, Massó J, Tuset M. Programa de incidentes de medicación: implementación, resultados y recomendaciones para su prevención. XX Congreso de la Sociedad Española de Calidad Asistencial, Octubre 2002, Pamplona.
34. Cullen DJ, Bates DW, Small SD, Cooper JB, Nemeskal AR, Leape LL. The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv. 1995;21:541-8.
35. Institute for Safe Medication Practices. The reports are in... or are they? Awareness of medication error reporting programs needs a boost. ISMP Medication Safety Alert! 2003;8:6 Feb.
36. Gordon BM. Medical errors: creating the tension for change. Am J Health-Syst Pharm. 2001;58:908-12.
37. Hritz RW, Everly JL, Care SA. Medication error identification is a key to prevention: a performance improvement approach. J Healthcare Qual. 2002;24:10-7.
38. Codina C, Robles MD, Castellá M, Creus IM, Massó J, López E, et al. Programa de notificación y registro de errores relacionados con los medicamentos. El Farmacéutico Hospitales. 2003;144:50-5.
39. American Hospital Association, Health Research and Education Trust, Institute for Safe Medication Practices. Pathways for medication safety. Leading a strategic planning effort, 2002.
40. Institute for Healthcare Improvement. Trigger tool for measuring adverse drug events. Boston (MA): IHI; 2003.
41. Gandhi TK, Bates DW. Computer adverse drug event (ADE) detection and alerts. En: Making health care safer: a critical analysis of patient safety practices. Rockville (MD): Agency for Healthcare Research and Quality, July 2001. AHRQ publication n.o 01-E058.
42. Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991;266:2847-51.
43. Evans RS, Pestotnik SL, Classen DC, Horn SD, Bass SB, Burke JP. Preventing adverse drug events in hospitalized patients. Ann Pharmacother. 1994;28:523-7.
44. Raschke RA, Gollihare B, Wunderlich TA, Guirdry JR, Leibowitz AI, Peirce JC, et al. A computer alert system to prevent injury from adverse drug events. Development and evaluation in a community teaching hospital. JAMA. 1998;280:1317-20.
45. Rozich JD, Haraden CR, Resar RK. Adverse drug event trigger tool: a practical methodology for measuring medication related harm. Qual Saf Health Care. 2003;12:194-200.
46. Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, et al. System analysis of adverse drug events. JAMA. 1995;274:35-43.
47. Otero López MJ, Codina Jané C, Tamés Alonso MJ, Pérez Encinas M, en representación del Grupo de Trabajo Ruiz-Jarabo 2000. Errores de medicación: estandarización de la terminología y clasificación. Resultados de la beca Ruiz-Jarabo 2000. Farmacia Hosp (Madrid). 2003;27:137-49.
48. National Coordinating Council for Medication Error Reporting and Prevention. NCCMERP Taxonomy of medication errors, 1998.
49. Hartwig SC, Denger SD, Schneider PJ. Severity-indexed, incident report-based medication error-reporting program. Am J Hosp Pharm. 1991;48:2611-6.
50. Cohen MR, Kilo CM. High-alert medications: safeguarding against errors. En: Cohen MR, editor. Medication Errors. Washington (DC): American Pharmaceutical Association; 1999.
51. ISMP-España. Instituto para el Uso Seguro de los Medicamentos. Notificación de errores al ISMP-España. Disponible en: www.usal.es/ismp
52. American Society for Healthcare Risk Management. Strategies and tips for maximizing failure mode and effect analysis in an organization. ASHRM J. 2002 (Summer);9-12.
53. ECRI. Proactive hazard analysis and health care policy. New York: Milbank Memorial Fund; 2002.
54. Cohen MR, Senders J, Davis NM. Failure mode and effect analysis: a novel approach to avoiding dangerous medication errors and accidents. Hosp Pharm. 1994;29:319-24,326-8, 330.
55. Otero MJ. Nuevas iniciativas para mejorar la seguridad de la utilizacion de los medicamentos en los hospitales. Rev Esp Salud Pública. 2004;78:323-39.
56. Hanold LS, Vinson BE, Rubino A. Evaluating and improving your medication use system. En: Cousins DD, editor. Medication use: a systems approach to reducing errors. Oakbrook Terrace (IL): Joint Commission; 1998. p. 75-115.
57. Leape LL, Berwick D. Safe health care: are we up to it? BMJ. 2000;320:725-6.